TherapeuticsMD TXMD
NASDAQ TXMD
$1.87 -0.03 (-1.38%)
As of: Oct 22, 2026 · 9:45 AM EDT

TherapeuticsMD (TXMD) EV to FCF (2022 - 2026)

Updated

TherapeuticsMD's (TXMD) EV to FCF was 8.26 for Q2 2026, up 15.2% from 7.17 a year earlier but down 4.7% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) EV to FCF (2022 - 2026) Analysis & Trends

For FY2025, EV to FCF at TherapeuticsMD was 7.69, up 85.1% from FY2024.

  • By year, EV to FCF came in at 4.15 in FY2024 and 0.40 in FY2022.
  • Five-year quarterly EV to FCF spans a low of 0.40 in Q4 2022 and a high of 8.66 in Q1 2026.
  • Year over year, EV to FCF has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 8.66 (Q1 2026), 7.69 (Q4 2025) and 2.57 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 TherapeuticsMD 21.69 Mn 21.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.26
Mar 31, 2026 8.66
Dec 31, 2025 7.69
Sep 30, 2025 2.57
Jun 30, 2025 7.17
Mar 31, 2025 2.39
Dec 31, 2024 4.15
Sep 30, 2023 1.80
Jun 30, 2023 0.83
Mar 31, 2023 1.00
Dec 31, 2022 0.40
Sep 30, 2022 0.91
API Access

TherapeuticsMD EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TXMD&period=max&api_key=YOUR_API_KEY